Raphaela Goldbach‐Mansky

Author

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Also Known As

Carol Glaser, Cole, Joe L., R Goldbach-Mansky, R. Goldbach-Mansky, Raphaela Goldbach-Mansky, Raphaela Goldbach‐Mansky, Raphaela T Goldbach-Mansky, Raphaela T. Goldbach-Mansky, Raphaela T. Goldbach‐Mansky

Publications

770

Citations

H-Index

Concepts

All Affiliations

National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Allergy and Infectious Diseases National Human Genome Research Institute National Institutes of Health

About

Raphaela Goldbach‐Mansky is an author at National Institute of Arthritis and Musculoskeletal and Skin Diseases specializing in medicine, inflammation, and women's health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	252
2	Public Health	1	1	95
3	Cell Biology	1	1	157
4	Cellular Physiology	1	1	157
5	Endocrinology	1	1	95

Raphaela Goldbach‐Mansky

Publications

678

Citations

H-Index

Page 1

	Year	Citations
A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndrome Raphaela Goldbach‐Mansky, Sharukh D. Shroff, Mildred Wilson, Arthritis & Rheumatism	2008	228
STEEP mediates STING ER exit and activation of signaling Bao‐cun Zhang, Ramya Nandakumar, Line S. Reinert, Nature Immunology Signal TransductionIntercellular CommunicationCellular BiochemistryMedicineCell Biology	2020	157
Low prevalence of antibodies to glucose‐6‐phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders Isao Matsumoto, David M. Lee, Raphaela Goldbach‐Mansky, Arthritis & Rheumatism	2003	141
Brief Report: Anakinra Use During Pregnancy in Patients With Cryopyrin‐Associated Periodic Syndromes Zenas Chang, Catherine Y. Spong, Adriana A. de Jesus, Arthritis & Rheumatology ImmunologyReproductive HealthGynecologyPregnancy CourseHigh-risk Pregnancy	2014	95
Excess Serum Interleukin‐18 Distinguishes Patients With Pathogenic Mutations in <scp> <i>PSTPIP1</i> </scp> Deborah L. Stone, Amanda K. Ombrello, Juan I. Aróstegui, Arthritis & Rheumatology	2021	34
Preliminary response to Janus kinase inhibition with baricitinib in chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE) Gina Montealegre, Adam Reinhardt, Paul Brogan, Pediatric Rheumatology	2015	23

Page 1